Alpha Teknova (TKNO) Cost of Revenue (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Cost of Revenue of $7.3 million for Q1 2026, up 7.44% year-over-year from $6.8 million in Q1 2025, and up 8.2% quarter-over-quarter from $6.7 million in Q4 2025.
Alpha Teknova (TKNO) Cost of Revenue (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Cost of Revenue for 7 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 7.44% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $27.6 million (down 8.73% YoY), while the FY2025 annual figure was $27.1 million, down 11.26% from the prior year.
- Cost of Revenue climbed to $7.3 million in Q1 2026 per TKNO's latest filing, from $6.7 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $9.5 million in Q3 2024 and bottomed at $5.8 million in Q4 2022.
- Historically, Cost of Revenue has averaged $6.8 million across 5 years, with a median of $6.7 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue surged 43.05% — and 2025, when it slipped 23.59%.
- Alpha Teknova's Cost of Revenue stood at $5.8 million in 2022, then grew by 12.99% to $6.5 million in 2023, then rose by 9.26% to $7.1 million in 2024, then dropped by 5.56% to $6.7 million in 2025, then advanced by 8.2% to $7.3 million in 2026.
- Business Quant data shows TKNO's Cost of Revenue at $7.3 million in Q1 2026, $6.7 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.30 Mn |
| Jun 30, 2026 | 7.30 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Sep 30, 2025 | 7.25 Mn |
| Sep 30, 2025 | 7.25 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.08 Mn |